CDY2A

Across TCGA pan-cancer cohorts, CDY2A RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated CDY2A data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CDY2A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDY2A expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

COAD, KIRC, and LUSC are the cancer types where CDY2A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	III,IV	0.054	0.793	<.001	27	view →
KIRC	DFS	Tertile	II,III,IV	1.000	0.513	.031	24	view →
LUSC	DFS	Tertile	III,IV	0.203	0.662	.018	18	view →
CESC	OS	Tertile	All	0.626	0.874	.023	18	view →
ESCA	OS	Tertile	All	0.211	0.876	.028	18	view →
LIHC	DFS	Tertile	All	0.174	0.545	.019	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CDY2A–COAD (OS)

Open the COAD breakdown →